Interleukin-25 Negatively Controls Pathogenic Responses in the Gut

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|10|3|187-191

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.10, Iss.3, 2011-06, pp. : 187-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-21 (IL-21) Controls Inflammatory Pathways in the Gut

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 4, 2007-12 ,pp. : 288-291

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-25: Key Regulator of Inflammatory and Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. : 3781-3785

Bentham Science Publishers

Access to resources Recommend Favorite

The Interleukin-17/Interleukin-22 Innate Axis in the Gut as a New Drug Target in Allergic-Inflammatory and Autoimmune Diseases. A Working Hypothesis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 2, 2014-06 ,pp. : 145-151

Bentham Science Publishers

Access to resources Recommend Favorite

The Release and Induced Immune Responses of a Plant-Made and Delivered Antigen in the Mouse Gut

By  

Current Drug Delivery, Vol. 8, Iss. 6, 2011-11 ,pp. : 612-621

Bentham Science Publishers

Access to resources Recommend Favorite

Blockade of PAF receptors controls interleukin-8 production by regulating the activation of neutrophil CD11/CD18

By Au B.-t.   Teixeira M.M.   Collins P.D.   Williams T.J.  

European Journal of Pharmacology, Vol. 425, Iss. 1, 2001-08 ,pp. : 65-71

Elsevier

Access to resources Recommend Favorite